Vertex Pharma shares soar 23% as company ups its cystic fibrosis offerings By: MarketWatch March 29, 2017 at 11:09 AM EDT Wall Street analysts were unusually impressed by the Tuesday results from a trial of a cystic fibrosis treatment. Read More >> Related Stocks: Vertex Pharmaceuticals